Eli Lilly and Co (NYSE:LLY)
| 446.06 Delayed Data As of Jun 09 |  +0.40 / +0.09%Today’s Change | 283.11 Today|||52-Week Range 454.95 | +21.93% Year-to-Date |
Latest LLY News | Press Releases
| Eli Lilly (LLY) Gains But Lags Market: What You Should Know Jun 09 / Zacks.com - Paid Partner Content | Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Jun 01 / Zacks.com - Paid Partner Content |
| Biogen (BIIB), Eisai's Alzheimer Drug Likely to Get Full FDA Nod Jun 08 / Zacks.com - Paid Partner Content | Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk, Roche and Novartis Jun 01 / Zacks.com - Paid Partner Content |
| Could Pfizer Have an Ozempic Killer on the Way? Jun 05 / MotleyFool.com - Paid Partner Content | 5 Large Drug Stocks to Watch From a Thriving Industry May 31 / Zacks.com - Paid Partner Content |
| Could AI Boost Growth at Medtronic? Jun 03 / MotleyFool.com - Paid Partner Content | 2 Newly Minted AI Stocks to Buy Right Now May 31 / MotleyFool.com - Paid Partner Content |
| Buy These 3 Top-Ranked ETFs and Never Sell Jun 02 / Zacks.com - Paid Partner Content | Better Dividend Stock: Eli Lilly or Novo Nordisk? May 30 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 445.66 |
| Today’s open | 447.41 |
| Day’s range | 442.80 - 448.77 |
| Volume | 2,082,341 |
| Average volume (3 months) | 3,256,896 |
| Market cap | $419.9B |
Data as of 4:00pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | +12.53% |
| Earnings growth (this year) | +9.35% |
| Earnings growth (next 5 years) | +24.20% |
| Revenue growth (last year) | +0.79% |
| P/E ratio | 70.9 |
| Price/Sales | 11.60 |
| Price/Book | 39.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| JNJJohnson & Johnson | -0.24 | -0.15% |
| MRKMerck | +0.43 | +0.39% |
| NVONovo Nordisk | -1.38 | -0.87% |
| ABBVAbbVie | +0.50 | +0.36% |
Data as of 4:00pm ET, 06/09/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | $1.99 |
| Annual revenue (last year) | $28.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 21.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
